ERS International Congress, 2020: highlights from the Epidemiology and Environment Assembly
- Diana A van der Plaat1,
- Aino K Rantala2,3,
- Sheikh M Alif4,
- Dilek Karadoğan5,
- Yutong Cai6 and
- Orianne Dumas7⇑
- 1National Heart and Lung Institute, Imperial College London, London, UK
- 2Center for Environmental and Respiratory Health Research, University of Oulu, Oulu, Finland
- 3Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway
- 4Monash Centre for Occupational & Environmental Health, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
- 5Department of Chest Diseases, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey
- 6Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK
- 7Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Équipe d'Épidémiologie respiratoire intégrative, CESP, Villejuif, France
- Orianne Dumas, Inserm, CESP, Équipe d'Épidémiologie respiratoire integrative, 16, avenue Paul Vaillant Couturier, 94807 Villejuif cedex, France. E-mail: orianne.dumas{at}inserm.fr
Abstract
In this article, early career members of the Epidemiology and Environment Assembly of the European Respiratory Society (ERS) summarise a selection of five sessions from the Society's 2020 virtual congress. The topics covered include risk factors for chronic respiratory diseases over the life course, from early life origins to occupational exposures in adulthood, and the interplay between these risk factors, including gene-environment interactions. Novel results were also presented on smoking prevention and potential risks of vaping. Finally, the challenges and opportunities for epidemiological and environmental research brought by the coronavirus disease-2019 (COVID-19) pandemic were a major topic of this year's congress.
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. van der Plaat has nothing to disclose.
Conflict of interest: Dr. Rantala has nothing to disclose.
Conflict of interest: Dr. Alif has nothing to disclose.
Conflict of interest: Dr. Karadoğan has nothing to disclose.
Conflict of interest: Dr. Cai has nothing to disclose.
Conflict of interest: Dr. Dumas has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received November 13, 2020.
- Accepted January 13, 2021.
- ©The authors 2021
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org